Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
Hereditary cancer syndromes constitute approximately 10% of all cancers. Cascade testing involves testing of at-risk relatives to determine if they carry the familial pathogenic variant. Despite growing efforts targeted at improving cascade testing uptake, current literature continues to reflect poo...
Main Authors: | Chiang, Jianbang, Chua, Ziyang, Chan, Jia Ying, Sule, Ashita Ashish, Loke, Wan Hsein, Lum, Elaine, Ong, Marcus Eng Hock, Graves, Nicholas, Ngeow, Joanne |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/178841 |
Similar Items
-
Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
by: Jianbang Chiang, et al.
Published: (2024-04-01) -
Predictive Testing for Tumor Predisposition Syndromes in Pediatric Relatives: An Asian Experience
by: Jianbang Chiang, et al.
Published: (2020-10-01) -
Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis
by: Muhammad Danyal Ahsan, et al.
Published: (2023-12-01) -
Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing
by: Konstantinos Agiannitopoulos, et al.
Published: (2023-10-01) -
Predictive testing for tumor predisposition syndromes in pediatric relatives : an Asian experience
by: Chiang, Jianbang, et al.
Published: (2020)